LGALS1 and central nervous system cancer: The protein-protein interaction between FAM289 and Galectin-1 could activate the ERK pathway to up regulate DNMTs expression and increase stem-like properties gene expression, and thus affecting its drug sensitivity of TMZ in the treatment of gliomas (Fig. 8).